martes, 12 de marzo de 2019

Bristol scrambles to push Celgene deal. Are the odds that high? - STAT

Bristol scrambles to push Celgene deal. Are the odds that high? - STAT

Cancer Briefing

STAT Plus: Bristol scrambles to push Celgene deal, but are the odds as high as some think?

By ED SILVERMAN


MEL EVANS/AP
Bristol-Myers Squibb called a meeting with analysts in a “semi-urgent fashion” in hopes of convincing investors its bid for Celgene is a good deal.







No hay comentarios: